Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HER Receptor Role in Prostate Cancer Prognosis and Bicalutamide Response
NCT00418080Phase 2Completed
- Sponsor
- Università degli Studi dell'Aquila
- Start
- Apr 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bicalutamide in prostate cancer (PCa), sponsored by Università degli Studi dell'Aquila. Started Apr 2002; status: completed.
02
Drugs
bicalutamide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00418080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00418080.